- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07681934
Swaddling and Breast Milk Odor for Stress and Comfort in Late Preterm Babies Receiving High-Flow Breathing Support Through the Nose
The Effect of the Safe Swaddling Method and the Scent of Breast Milk on Physiological Parameters, Stress, and Comfort Levels in Premature Newborns Receiving Mechanical Ventilator Support: A Randomized Controlled Study
This study compared two approaches to reducing stress and improving comfort in babies born between 34 and 36 completed weeks of pregnancy who were receiving high-flow breathing support through small tubes in the nose.
Seventy-two babies were assigned by chance to one of three groups, with 24 babies in each group. One group was gently swaddled for 20 minutes. A second group was exposed for 20 minutes to the smell of freshly expressed milk from each baby's own mother. The third group received the neonatal intensive care unit's usual care and was observed for 20 minutes.
The study team assessed stress and comfort and recorded heart rate, breathing rate, blood oxygen level, and body temperature at the start of the observation period and again at 5 and 20 minutes. The purpose was to compare how these measures changed over time across the three groups.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Karatay
-
Konya, Karatay, Turkije (Türkiye), 42040
- KTO Karatay University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Gestational age at birth of 34 weeks 0 days to 36 weeks 6 days, inclusive.
- Within the first 28 days of life at enrollment.
- Receiving noninvasive respiratory support via a high-flow nasal cannula (HFNC).
- Birth weight of at least 1,500 g.
- The infant's mother was able to provide expressed breast milk.
- No clinical condition that precluded safe positioning or swaddling.
- Written informed consent obtained from a parent.
Exclusion Criteria:
- A painful procedure within 1 hour before the start of the planned study session.
- Receipt of a medication with analgesic or sedative effects within 6 hours before the start of the planned study session.
- Previous surgery.
- An active or treatment-requiring clinical condition that could affect physiological measurements or the stress response, such as hypoglycemia, hyperbilirubinemia, or acute infection.
- Cerebral hypoxia or ischemia.
- Intraventricular hemorrhage.
- A major congenital anomaly.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Maternal Breast Milk Odor
Infants were exposed for 20 minutes to the odor of freshly expressed breast milk from their own mothers. Ten drops of milk were applied to sterile gauze placed in a sterile container. The container was positioned inside the incubator approximately 1-2 cm from the infant's nose and remained in place throughout the exposure period. |
Ten drops of freshly expressed breast milk from each infant's own mother were applied to sterile gauze in a sterile container. The container was placed inside the incubator near the infant's nose for 20 minutes. |
|
Experimenteel: Safe Swaddling
Infants were positioned supine and swaddled for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The upper limbs were held alongside the trunk in slight flexion. The lower limbs were left free to allow hip flexion and abduction. The cloth was secured loosely enough to permit chest expansion and spontaneous movement. |
Infants were swaddled in the supine position for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The cloth was secured loosely to allow chest expansion and spontaneous movement, and the lower limbs were left free to permit hip flexion and abduction. |
|
Geen tussenkomst: Standard Care
Infants received the neonatal intensive care unit's standard care during a 20-minute observation period. No additional study intervention was administered. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Newborn Stress Scale Total Score Over Time
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Stress was assessed using the Newborn Stress Scale. The scale comprises eight observational domains, each scored from 0 to 2. Total scores range from 0 to 16, with higher scores indicating greater stress. Changes in total scores across the three assessment time points were compared among the study groups. |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Premature Infant Comfort Scale Total Score
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Comfort was assessed using the Turkish version of the Premature Infant Comfort Scale. Seven indicators are each scored from 1 to 5. Total scores range from 7 to 35, with lower scores indicating greater comfort. |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
|
Heart Rate
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Heart rate was read directly from the bedside monitor and recorded in beats per minute. |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
|
Respiratory Rate
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Respiratory rate was read directly from the bedside monitor and recorded in breaths per minute. |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
|
Peripheral Oxygen Saturation (SpO₂)
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Peripheral oxygen saturation was read directly from the bedside monitor and recorded as a percentage. |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
|
Body Temperature
Tijdsspanne: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Body temperature was read directly from the bedside monitor and recorded in degrees Celsius (°C). |
At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Hediye Karakoç, KTO Karatay Üniversitesi
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- KARATAYU-SBF-ES-01
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Security
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .